Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Mononuclear Cells in Chronic Ischemic Heart Disease
NCT00824005Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Mar 2009
- Primary completion
- Nov 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in chronic ischemic heart disease (CIHD), left ventricular dysfunction, ischemic cardiomyopathy (ICM), sponsored by UTHealth Houston. Started Mar 2009; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
chronic ischemic heart disease (CIHD)left ventricular dysfunctionischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT00824005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824005.